Yunteng Q. Wu

Shanghai Key Laboratory Of Stomatology
Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications

Epithelial Edar Is Responsible for Dental Anomalies in HED.

Epithelial Edar Is Responsible for Dental Anomalies in HED.

Journal: Journal of dental research
Published: July 18, 2026

Advances in neoadjuvant therapy for EGFR-mutant non-small cell lung cancer

Advances in neoadjuvant therapy for EGFR-mutant non-small cell lung cancer

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: June 22, 2026

Pembrolizumab With Anlotinib in Advanced Oral Mucosal Melanoma: A Retrospective Trial.

Pembrolizumab With Anlotinib in Advanced Oral Mucosal Melanoma: A Retrospective Trial.

Journal: Oral diseases
Published: August 06, 2025

Neoadjuvant Pembrolizumab Combined with Chemotherapy for Locally Advanced Resectable Oral and Oropharyngeal Squamous Cell Carcinomas: A Single-center Retrospective Study.

Neoadjuvant Pembrolizumab Combined with Chemotherapy for Locally Advanced Resectable Oral and Oropharyngeal Squamous Cell Carcinomas: A Single-center Retrospective Study.

Journal: Journal of Cancer
Published: July 22, 2025

Dalpicilib combined with cetuximab in patients with HPV-negative, anti-PD-1-resistant recurrent or metastatic head and neck squamous cell carcinoma: A phase II trial.

Dalpicilib combined with cetuximab in patients with HPV-negative, anti-PD-1-resistant recurrent or metastatic head and neck squamous cell carcinoma: A phase II trial.

Journal: Nature communications
Published: March 30, 2025

Expert consensus on cryosurgery therapy of mucosal melanoma on head and neck.

Expert consensus on cryosurgery therapy of mucosal melanoma on head and neck.

Journal: Cryobiology
Published: March 30, 2025

A scientometric study on research characteristics and trends of amyloidosis involving the oral cavity.

A scientometric study on research characteristics and trends of amyloidosis involving the oral cavity.

Journal: Journal of dental sciences
Published: December 04, 2024

Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trial.

Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trial.

Journal: Nature medicine
Published: January 25, 2024

The clinical outcome of pembrolizumab for patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a single center, real world study in China.

The clinical outcome of pembrolizumab for patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a single center, real world study in China.

Journal: Frontiers in oncology
Published: December 23, 2023

The efficacy and safety of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with advanced head and neck mucosal melanoma harboring CDK4 amplification.

The efficacy and safety of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with advanced head and neck mucosal melanoma harboring CDK4 amplification.

Journal: BMC medicine
Published: July 01, 2023

Single-cell analysis reveals a unique microenvironment in peri-implantitis.

Single-cell analysis reveals a unique microenvironment in peri-implantitis.

Journal: Journal of clinical periodontology
Published: April 28, 2023

A pilot study of camrelizumab with docetaxel and cisplatin for the first line treatment in recurrent/metastatic oral squamous cell carcinoma.

A pilot study of camrelizumab with docetaxel and cisplatin for the first line treatment in recurrent/metastatic oral squamous cell carcinoma.

Journal: MedComm
Published: March 22, 2023
Showing 1-12 of 39

Last Updated: 09/26/2026